checkAd
    Adaptive Biotechnologies Corporation Aktie
    3,4500
     
    USD
    -0,29 %
    -0,0100 USD
    Letzter Kurs 23:20:00 Nasdaq
    3,4400
     
    USD
    400 STK
    Geldkurs 22:02:00
    3,4500
     
    USD
    6.800 STK
    Briefkurs 22:02:00
    ISIN: US00650F1093 · WKN: A2PLR5 · SYM: ADPT · USA

    Neueste Nachrichten

    Fokus Aktien mit extremen Handelsvolumen am Donnerstag, den 16.05.2024
    16.05.24 · wO Chartvergleich · ATI
    Adaptive Biotechnologies Reports First Quarter 2024 Financial Results
    07.05.24 · globenewswire · Adaptive Biotechnologies Corporation
    Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024
    17.04.24 · globenewswire · Adaptive Biotechnologies Corporation
    Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue
    02.04.24 · globenewswire · Adaptive Biotechnologies Corporation
    Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024
    27.03.24 · globenewswire · Adaptive Biotechnologies Corporation
    Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference
    22.02.24 · globenewswire · Adaptive Biotechnologies Corporation
    Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results
    14.02.24 · globenewswire · Adaptive Biotechnologies Corporation
    Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024
    29.01.24 · globenewswire · Adaptive Biotechnologies Corporation
    Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    27.12.23 · globenewswire · Adaptive Biotechnologies Corporation
    Adaptive Biotechnologies Reports Third Quarter 2023 Financial Results and Provides Business Update
    09.11.23 · globenewswire · Adaptive Biotechnologies Corporation
    Adaptive Biotechnologies Announces New Translational Collaboration to Measure Minimal Residual Disease with clonoSEQ Assay Across BeiGene’s Lymphoid Malignancy Pipeline
    07.11.23 · globenewswire · Adaptive Biotechnologies Corporation
    Adaptive Announces Launch of Epic Integration for clonoSEQ
    13.09.23 · globenewswire · Adaptive Biotechnologies Corporation